These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 292811

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations.
    Gorelik E, Fogel M, Segal S, Feldman M.
    J Supramol Struct; 1979; 12(3):385-402. PubMed ID: 94933
    [Abstract] [Full Text] [Related]

  • 3. Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones.
    Aboud M, Kingsmore S, Segal S.
    Nat Immun; 1993; 12(1):17-24. PubMed ID: 8431660
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
    Begovic M, Herberman R, Gorelik E.
    Cancer Res; 1991 Oct 01; 51(19):5153-9. PubMed ID: 1913641
    [Abstract] [Full Text] [Related]

  • 7. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice.
    Talmadge JE, Meyers KM, Prieur DJ, Starkey JR.
    J Natl Cancer Inst; 1980 Nov 01; 65(5):929-35. PubMed ID: 6933263
    [Abstract] [Full Text] [Related]

  • 8. Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development.
    Kurosawa S, Matsuzaki G, Harada M, Ando T, Nomoto K.
    Eur J Immunol; 1993 May 01; 23(5):1029-33. PubMed ID: 8477798
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
    Gorelik E, Segal S, Feldman M.
    J Natl Cancer Inst; 1980 Dec 01; 65(6):1257-64. PubMed ID: 6933271
    [Abstract] [Full Text] [Related]

  • 11. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
    Nokihara H, Yanagawa H, Nishioka Y, Yano S, Mukaida N, Matsushima K, Sone S.
    Cancer Res; 2000 Dec 15; 60(24):7002-7. PubMed ID: 11156403
    [Abstract] [Full Text] [Related]

  • 12. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
    Peppoloni S, Herberman RB, Gorelik E.
    Cancer Res; 1985 Jun 15; 45(6):2560-6. PubMed ID: 2580624
    [Abstract] [Full Text] [Related]

  • 13. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT.
    J Clin Invest; 1993 Dec 15; 92(6):2569-76. PubMed ID: 7504687
    [Abstract] [Full Text] [Related]

  • 14. Tumor burden impairment of murine natural killer cell cytotoxicity.
    Boom M, Pollock RE, Shenk RR, Stanford S.
    Invasion Metastasis; 1988 Dec 15; 8(2):118-32. PubMed ID: 3360592
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selecting, accelerating and suppressing interactions between macrophages and tumor cells.
    De Baetselier P, Kapon A, Katzav S, Tzehoval E, Dekegel D, Segal S, Feldman M.
    Invasion Metastasis; 1985 Dec 15; 5(2):106-24. PubMed ID: 3884534
    [Abstract] [Full Text] [Related]

  • 17. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
    Budzyński W.
    Arch Immunol Ther Exp (Warsz); 1984 Dec 15; 32(2):185-9. PubMed ID: 6487051
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA, Walker MC, Phillips-Quagliata JM.
    Cancer Res; 1986 Jan 15; 46(1):190-7. PubMed ID: 3484380
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.